+

KR20020030141A - Cosmetic material containing Padina Pavonica extract - Google Patents

Cosmetic material containing Padina Pavonica extract Download PDF

Info

Publication number
KR20020030141A
KR20020030141A KR1020000060708A KR20000060708A KR20020030141A KR 20020030141 A KR20020030141 A KR 20020030141A KR 1020000060708 A KR1020000060708 A KR 1020000060708A KR 20000060708 A KR20000060708 A KR 20000060708A KR 20020030141 A KR20020030141 A KR 20020030141A
Authority
KR
South Korea
Prior art keywords
skin
extract
padinapabonica
synthesis
cosmetic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1020000060708A
Other languages
Korean (ko)
Other versions
KR100419134B1 (en
Inventor
주용준
조진훈
김효정
권철
남상인
Original Assignee
김해관
엔프라니 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김해관, 엔프라니 주식회사 filed Critical 김해관
Priority to KR10-2000-0060708A priority Critical patent/KR100419134B1/en
Publication of KR20020030141A publication Critical patent/KR20020030141A/en
Application granted granted Critical
Publication of KR100419134B1 publication Critical patent/KR100419134B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706Algae
    • A61K8/9711Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE: Provided is a cosmetic composition containing padina pavonica extract for skin protection. Particularly, the composition contains the extract of brown algae to improve wrinkles on the skin and make the skin firm. CONSTITUTION: The cosmetic composition is characterized by comprising 0.1-20.0 wt.% of padina pavonica extract which relieves skin stimulation, and increases skin texture and improves wrinkles on the skin by stimulating aminoglucan synthesis.

Description

파디나파보니카 추출물을 함유한 피부 보호용 화장료 조성물{Cosmetic material containing Padina Pavonica extract}Cosmetic composition for skin protection containing Padina Pabonica extract {Cosmetic material containing Padina Pavonica extract}

본 발명은 피부의 탄력 증진 효과와 자극 완화 효과가 있는 갈조류 추출물을 함유하는 화장료에 관한 것으로서, 보다 상세하게는 파디나파보니카 추출물의 글루코스 아미노글루칸 합성 촉진 효과에 의한 진피층 및 표피층의 피부 개선 및 자극 완화 그리고 프리라디컬 예방에 큰 효과가 있는 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic comprising a brown algae extract having an elasticity enhancing effect and a stimulating alleviating effect of the skin, and more particularly, skin improvement and stimulation of the dermal and epidermal layers by the glucose aminoglucan synthesis promoting effect of the padinapabonica extract. It relates to a cosmetic composition having a great effect on the relief and prevention of free radicals.

사람의 피부는 크게 외피층, 진피층, 그리고 피하조직으로 구성되어 있다. 그 중 진피 내의 주요한 세포인 섬유 아세포는 콜라겐, 엘라스틴, 또는 글루코스 아미노글루칸 등의 합성 및 분해 기능을 담당하는데, 이는 자외선에 의한 광노화, 프리라디컬에 의한 영향, 세포활성 감소 등의 원인으로 인해 그 증식 활성이 저하되므로 나이가 들어감에 따라 그 대사기능은 점차 떨어지게 된다. 더욱이 콜라겐 등의 구조는 턴-오버가 매우 길어 가교의 형성 등 여러 가지 수식, 변성을 받음으로써 탄력성의 저하 등 주름의 발생에 연관된 변화를 일으키기도 한다.Human skin is largely composed of the cortex, dermis and subcutaneous tissue. Among them, fibroblasts, the main cells in the dermis, are responsible for the synthesis and degradation of collagen, elastin, or glucose aminoglucan. As the proliferative activity decreases, the metabolic function gradually decreases with age. In addition, the structure of collagen and the like has a long turn-over, and thus undergoes various modifications and modifications, such as the formation of crosslinks, thereby causing changes related to the occurrence of wrinkles such as a decrease in elasticity.

최근 피부의 탄력 증진 및 주름 예방 등에 대한 관심이 커지면서 이에 효과적인 물질들에 대한 연구가 활발히 진행되어 왔는데, 대표적인 것이 레티노이드와 알파하이드록시 애시드(AHA), 베타하이드록시 애시드(BHA) 등의 하이드록시 애시드(HA) 등이다.Recently, as interest in increasing skin elasticity and preventing wrinkles has increased, studies on effective materials have been actively conducted. Representatives such as hydroxy acid such as retinoid, alpha hydroxy acid (AHA) and beta hydroxy acid (BHA) (HA) and the like.

하이드록시 애시드 및 레티노이드는 광 손상 또는 자연적으로 노화된 피부의 외관상 개선, 피부 미백, 주름 개선 등의 효과를 나타내는 것으로 입증되었다.Hydroxy acids and retinoids have been shown to have the effect of improving the appearance of light damage or naturally aged skin, skin whitening, wrinkle improvement and the like.

미국 특허 US 5939457호에서는 주름을 개선하고자 하이드록시 애시드를 이용한 방법이 공개되어 있고 US 5889054호에서는 피부의 개선 특히 주름 개선을 목적으로 베타하이드록시 애시드를 이용했음을 기술하고 있으며 US RE36068호에서는 광노화에 의한 피부조직을 개선하기 위해 레티노이드를 사용하여 효과를 나타냈음을 밝히고 있다.US Pat. No. 5,939,457 discloses a method using hydroxy acid to improve wrinkles, US Pat. No. 58,890,54 describes that beta hydroxy acid is used for skin improvement, in particular, for wrinkle improvement. The use of retinoids to improve skin tissue has been shown to be effective.

그럼에도 불구하고, 널리 알려진 바와 같이 상기 물질들은 상당한 효과를 얻기 위해서는 일정량 이상의 농도를 유지해야 하는데 이러한 고농도로 사용할 경우 피부에 대한 자극이 가장 큰 문제점으로 대두되었으며, 이에 따라 본래의 효능을 유지하면서도 자극을 줄일 수 있는 보완 방안이 연구되고 있다. 이와 관련, 미국특허 제5516793호에서는 하이드록시 애시드와 레티노이드를 포함하는 다양한 국부적 성분에 의해 야기되는 자극을 개선시키기 위한 아스코르빈산의 용도가 공개되어 있고 유럽 특허 제0631722호에는 글리콜산을 사용하여 레티놀에 의한 피부자극을 감소시키는 것이 개시되어 있다.Nevertheless, as is well known, the substances have to maintain a certain amount or more in order to obtain a significant effect, and when used at such high concentrations, the irritation to the skin has emerged as the biggest problem. Complementary measures to reduce this are being studied. In this regard, US Pat. No. 55,16793 discloses the use of ascorbic acid to ameliorate the stimulus caused by various local ingredients, including hydroxy acid and retinoids, and European Patent No. 0631722 employs retinol using glycolic acid. It is disclosed to reduce skin irritation by.

기타 천연 추출물들에 대한 연구도 활발히 이루어지고 있는데, 레티노이드와 하이드록시 애시드의 자극을 완화시킬 수 있는 천연 식물 추출물들에 대한 방법이 제시되고 있으며, 직접 안티 링클(anti-wrinkle) 효능을 갖는 원료들에 대한 탐구도 많이 진행되어 미국 특허 US 5869540호에서는 연령 증가에 따른 피부의 개선을 목적으로 허브 추출물을 사용하여 발명된 기술이 소개되기도 하였다.Other natural extracts are being actively researched, and methods for natural plant extracts that can alleviate the stimulation of retinoids and hydroxy acids have been proposed, and raw materials having direct anti-wrinkle efficacy In search of a lot of the US patent US Pat. No. 58,69,540, the invention of using the herbal extract for the purpose of improving the skin with increasing age was introduced.

그러나, 식물 추출물의 경우 아직까지 효능에 있어서 확실히 입증되지 않거나 효과가 나타난다고 하더라도 미약한 수준에 그치는 경우가 많으며, 이에 따라 피부에 자극이 없으면서도 효과가 높은 새로운 물질의 개발이 요구되고 있다.However, in the case of plant extracts, even if the effect is not yet clearly demonstrated or effective, it is often limited to a weak level. Accordingly, there is a demand for the development of a new substance having a high effect without irritation to the skin.

본 발명은 상기와 같은 종래 기술의 문제점을 해결하기 위한 것으로서 글루코스 아미노글루칸 합성을 촉진하여 피부의 탄력증진과 주름개선을 촉진할 수 있는 동시에 피부에 부작용이 없는 화장료 조성물을 제공하는 것을 목적으로 한다.The present invention is to solve the problems of the prior art as described above to promote glucose aminoglucan synthesis to promote skin elasticity and wrinkle improvement and to provide a cosmetic composition having no side effects on the skin.

상기한 목적을 달성하기 위해 본 발명에서는 갈조류인 파디나파보니카를 액상 파라핀으로 추출한 추출물을 함유한 화장료 조성물을 제공한다.In order to achieve the above object, the present invention provides a cosmetic composition containing an extract extracted with the liquid paraffin of the brown alga padinapabonica.

피부 내 결합조직에는 단백질 글루칸(Proteoglucan)이 풍부하게 있는데 이것은 다당류 단위와 단백질 단위로 구성된다. 그리고 여기에서 폴리 음이온들이 물이나 양이온들과 결합하여 세포간지질을 형성함으로써, 단백질 글루칸들이 피부 수분을 유지시켜 준다. 즉, 상당량의 수분을 매트릭스로 끌어들여 피부의 기능적 성질과 구조를 유지시켜 주게 된다.The connective tissue in the skin is rich in protein glucan, which consists of polysaccharide units and protein units. And here, poly anions combine with water or cations to form intercellular lipids, so that protein glucans maintain skin moisture. That is, a significant amount of moisture is drawn into the matrix to maintain the skin's functional properties and structure.

또한 단백질 글루칸은 관절 및 기계적 변형을 받기 쉬운 그 밖의 구조의 점성과 탄성을 결정하는데 중요한 역할을 하는데, 단백질 글루칸의 다당류 사슬인 글루코스 아미노글루칸은 아미노 당(Amino Sugar)의 유도체인 글루코사민 또는 갈락토사민의 어느 한가지를 함유하는 이당류 반복 단위로 구성된다.Protein glucan also plays an important role in determining the viscosity and elasticity of joints and other structures susceptible to mechanical deformation. Glucose aminoglucan, the polysaccharide chain of protein glucan, is a glucosamine or galactosamine derivative of the amino sugar. It consists of a disaccharide repeat unit containing any one of.

글루코스 아미노글루칸은 피부연결조직의 구성성분으로서 양이 많을 때는 피부를 탄력적으로 당겨 주며, 더 많을 땐 프리라디컬과 유해환경으로부터의 자극을 막는다. 주요한 종류로서 히아루론산(Hyaluronate), 콘드로이틴 설페이트(Condroitin sulfate), 케라탄 설페이트(Keratan sulfate), 헤파란 설페이트(Heparan sulfate), 헤파린(Heparin) 등이 있다.Glucose aminoglucan is a constituent of skin connective tissue, and when it is high in quantity, it pulls the skin elastically, and in more, it prevents free radicals and irritation from harmful environment. Major types include hyaluronate, chondroitin sulfate, keratan sulfate, heparan sulfate, heparin, and the like.

파디나파보니카는 갈조류에 속하는데, 이것은 칼슘 이온을 고정시킬 수 있는 세포 외부의 매트릭스로부터 만들어진 맥석(gangue)으로 보호되도록 코팅되어 있으며 매트릭스 내에 고정된 칼슘이 각질층을 보호하는 역할을 한다. 이 매트릭스는 피부에 중요한 조직인 글루코스 아미노글루칸의 기능과 조성을 가진 글루시드로 만들어졌다.Padinapabonica belongs to the brown algae, which is coated to be protected by a gangue made from an extracellular matrix that can immobilize calcium ions, and calcium immobilized within the matrix protects the stratum corneum. This matrix is made of glued seed with the function and composition of glucose aminoglucan, an important tissue for skin.

본 발명자는 in-vitro 실험을 통해 글루코스 아미노글루칸 합성을 자극하는 섬유아세포가 파디나파보니카 추출물을 인식하여 합성되는 양을 증가시킬 수 있음과 피부 자극이 감소한다는 것을 검증하였고, 이를 피부에 직접 적용한 in-vivo 실험에서도 각질세포에서 흡수된 후 섬유아세포에 작용하여 같은 역할을 하는 것을 확인하여 파디나파보니카 추출물이 함유된 화장료 조성물이 피부의 주름을 개선시키고 탄력을 증진시키며 외부 환경의 자극으로부터 피부를 보호할 수 있다는 사실을 알 수 있었다.The inventors have verified that fibroblasts stimulating glucose aminoglucan synthesis can increase the amount synthesized by recognizing padinapabonica extract and reduce skin irritation through in-vitro experiments, and applied it directly to the skin. In the in-vivo experiment, it was confirmed that the keratinocytes are absorbed by keratinocytes and act on the fibroblasts, so that the cosmetic composition containing padinapabonica extract improves wrinkles, promotes elasticity, and protects the skin from stimulation of the external environment. I could see that it can protect.

본 발명에 사용되는 파디나파보니카 추출물은 시판되는 제품으로 획득될 수 있으며 그 예로서 프랑스 ALBAN MULLER사 제품인 HPS-3를 들 수 있다.Padinapabonica extract used in the present invention can be obtained as a commercially available product, for example, HPS-3 manufactured by ALBAN MULLER company in France.

파디나파보니카 추출물은 화장료 중에서 로션, 크림, 에센스, 선스크린제, 페이셜팩 이외 기타 유상 첨가가 가능한 제품에 적용 가능하며, 그 함량이 0.1% 이하의 농도일 때에는 가시적인 효과를 기대할 수 없고 20% 이상의 농도에서는 함량의 증가에 비례하여 효과의 증가가 나타나지 않는 것으로 밝혀졌다. 따라서 경제성과 효과를 함께 고려할 때 파디나파보니카 추출물의 함량은 0.1 ~ 20.0 중량%가 바람직하다.Padinapabonica extract can be applied to cosmetics that can be added to lotions, creams, essences, sunscreens, facial packs and other oils. When the content is less than 0.1%, no visible effect is expected At concentrations above%, no increase in effect was found to be proportional to the increase in content. Therefore, in consideration of economics and effects, the content of the padinapabonica extract is preferably 0.1 to 20.0% by weight.

이하 실시예 및 비교예에 의해서 본 발명을 구체적으로 설명한다. 다만, 아래 실시예에 의해서 본 발명의 범위가 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail with reference to Examples and Comparative Examples. However, the scope of the present invention is not limited by the following examples.

〈실시예 및 비교예〉<Example and Comparative Example>

아래 표 1에 기재된 바와 같은 성분 및 성분비를 사용하여 화장료 조성물을 제조하였다.A cosmetic composition was prepared using the components and the component ratios as described in Table 1 below.

표 1)Table 1

원료명Raw material name 실시예 1Example 1 비교예 1Comparative Example 1 실시예 2Example 2 비교예 2Comparative Example 2 글리세린glycerin 3.003.00 3.003.00 3.003.00 3.003.00 1,3-부틸렌글리콜1,3-butylene glycol 2.002.00 2.002.00 2.002.00 2.002.00 세틸알코올Cetyl alcohol 2.002.00 2.002.00 2.002.00 2.002.00 쉐어 버터Shea Butter 1.001.00 1.001.00 1.001.00 1.001.00 폴리솔베이트 60Polysorbate 60 1.001.00 1.001.00 1.001.00 1.001.00 옥틸 팔미테이트Octyl palmitate 5.005.00 5.005.00 5.005.00 5.005.00 세테아릴알코올/세테아레스-20Cetearyl Alcohol / Ceteares-20 3.003.00 3.003.00 3.003.00 3.003.00 카보머Carbomer 0.100.10 0.100.10 0.100.10 0.100.10 트리에탄올아민Triethanolamine 0.100.10 0.100.10 0.100.10 0.100.10 방부제antiseptic 0.200.20 0.200.20 0.200.20 0.200.20 산화방지제Antioxidant 0.010.01 0.010.01 0.010.01 0.010.01 향료Spices 0.100.10 0.100.10 0.100.10 0.100.10 파디나파보니카 추출물Padina Pabonica Extract 5.005.00 -- 5.005.00 -- 글리콜릭 애시드(AHA)Glycolic Acid (AHA) -- -- 3.003.00 3.003.00 정제수Purified water To 100To 100 To 100To 100 To 100To 100 To 100To 100

실험방법; 수상부와 유상부의 조성을 각각 75℃까지 가열하여 완전용해시키고 수상부에 유상부를 가하여 호모믹서로 규질교반하여 유화시키고 중화한 후 서서히 냉각시켜 45℃가 되면 파디나파보니카 추출물과 기타 첨가물을 첨가하고 30℃까지 냉각 Experimental method ; Dissolve the composition of the water phase part and oil phase part to 75 ℃, completely dissolve it, add the oil phase part to the water phase part, and stir it with a homomixer to emulsify it, neutralize it, and then slowly cool it. When it reaches 45 ° C, add padinapabonica extract and other additives. Cool down to 30 ℃

1. 파디나파보니카 추출물에 의한 글루코스 아미노글루칸(GAGs) 합성 증가 실험1. Increased glucose aminoglucan (GAGs) synthesis by padinapabonica extract

파디나파보니카 추출물 5%가 함유된 화장료 용액과 함유되지 않은 화장료 용액으로 각각 처리한 조직에서 검취된 세포들을 세포층의 밀도가 어느 정도 높아질 때까지 증식시키고 트립신으로 처리한 후 셀 컬처를 3, 4차례 실시하는 과정을 몇 차례 반복하여 필요한 샘플을 얻어 글루코스 아미노글루칸(GAGs)의 합성 증가 측정 실험에 사용하였다. 글루코스 아미노글루칸(GAGs)의 합성은 블리스칸 방법으로 측정되었으며 이 방법은 용제에 용해시킨 후 원심분리하여 얻어진 글루코스 아미노글루칸(GAGs)의 특정한 컬러 콤플렉스의 흡광도를 측정하는 방법이며 글루코스 아미노글루칸(GAGs)의 양은 ㎍/㎖로 표시된다.In the tissues treated with the cosmetic solution containing 5% of padinapabonica extract and the cosmetic solution containing no cosmetic solution, the cells were grown until the density of the cell layer was increased to some extent and treated with trypsin. The procedure was repeated several times to obtain the required samples and to use them in experiments to increase the synthesis of glucose aminoglucans (GAGs). Synthesis of glucose aminoglucans (GAGs) was determined by the Bliskan method, which measures the absorbance of specific color complexes of glucose aminoglucans (GAGs) obtained by dissolving in a solvent and centrifuging. Glucose aminoglucans (GAGs) The amount of is expressed in μg / ml.

표 2) 파디나파보니카 추출물에 의한 글루코스 아미노글루칸(GAGs) 합성 증가량(㎍/㎖)Table 2) Synthesis of Glucose Aminoglucans (GAGs) by Padinapabonica Extract (μg / ml)

구 분division 1일 경과1 day past 3일 경과3 days elapsed 6일 경과6 days past 실시예 1 처방Example 1 Prescription 0.480.48 0.750.75 0.990.99 비교예 1 처방Comparative Example 1 Prescription 0.210.21 0.410.41 0.550.55

상기 실험 결과로 파디나파보니카 추출물이 함유된 화장료로 처리한 배양 세포 시료가 비교 시료에 비해 글루코스 아미노글루칸(GAGs) 합성을 크게 촉진시킨다는 것을 알 수 있고 이것은 곧 피부 조직의 탄력증진과 주름개선의 효과를 가져오게 된다.As a result of the experiment, it can be seen that the cultured cell sample treated with the cosmetic containing Padinapabonica extract greatly promoted the synthesis of glucose aminoglucans (GAGs) compared to the comparative samples, which is used to improve skin tissue elasticity and improve wrinkles. Will have an effect.

2. 섬유아세포의 글루코스 아미노글루칸(GAGs) 합성에 미치는 각질세포의 영향2. Effect of keratinocytes on the synthesis of glucose aminoglucans (GAGs) in fibroblasts

사람 피부 샘플을 1㎜ 두께, 4㎟ 넓이로 채취하여 전 처리한 후 진피층에서 섬유아세포를 분리하는 한편, 표피층에서는 각질세포를 분리하여 각각 파디나파보니카 추출물 5% 함유 화장료 용액으로 처리한 것과 처리하지 않은 것을 인큐베이션시키고 각질세포의 성장요소를 제거한 후 3회 헹군다. 이 과정에서 파디나파보니카 추출물로 처리한 시료에서는 파디나파보니카 추출물도 함께 제거한다. 이렇게 처리하여 다시 인큐베이션시킨 배양 시료의 상등액을 진피층에서 분리한 섬유아세포에 가하여 상등액의 함량에 따른 글루코스 아미노글루칸(GAGs) 합성의 증가를 점검하였다.Human skin samples were collected 1 mm thick and 4 mm wide, pretreated and separated from the fibroblasts from the dermal layer, while keratinocytes were separated from the epidermal layer and treated with a cosmetic solution containing 5% Padinapabonica extract, respectively. Incubate what is not done and rinse three times after removing the growth factor of keratinocytes. In this process, the padinapabonica extract is also removed from the sample treated with the padinapabonica extract. The supernatant of the culture sample thus incubated and re-incubated was added to fibroblasts isolated from the dermal layer, and the increase in the synthesis of glucose aminoglucan (GAGs) according to the content of the supernatant was examined.

표 3) 배양된 각질세포(케라티노사이트) 상등액 함량에 의한 글루코스 아미노글루칸(GAGs) 합성 증가량(㎍/㎖)Table 3) Glucose Aminoglucan (GAGs) Synthesis Increase by the Cultured Keratinocyte Supernatant Content (µg / ml)

구 분division controlcontrol 10%10% 20%20% 40%40% 80%80% 100%100% 실시예 1 처방Example 1 Prescription 0.850.85 0.900.90 1.051.05 1.201.20 1.301.30 1.351.35 비교예 1 처방Comparative Example 1 Prescription 0.850.85 0.800.80 0.750.75 0.850.85 0.900.90 0.800.80

상기 실험 결과로 파디나파보니카 추출물로 처리된 각질세포가 섬유아세포에 의한 글루코스 아미노글루칸(GAGs)의 합성을 촉진한다는 사실을 알 수 있고 이것은 표피와 진피 사이에 세포간 커뮤니케이션이 이루어진다고 볼 수 있다. 즉 매우 효과적인 피부 노화방지 성분이라고 할 수 있다.The experimental results show that keratinocytes treated with Padinapabonica extract promote the synthesis of glucose aminoglucans (GAGs) by fibroblasts, which indicates that intercellular communication between the epidermis and the dermis. . That is a very effective skin anti-aging ingredient.

3. 파디나파보니카 추출물에 의한 자극 완화 실험 (패치 실험)3. Stimulation Relief Experiment with Padinapabonica Extract (Patch Experiment)

피부 자극 완화 정도를 확인하기 위해 여성 실험자 20명을 상대로 상박부 안쪽에 실시예 2 처방과 비교예 2 처방 시료를 가지고 패치 테스트를 적용한 후 24시간 후에 자극 정도를 평가하였다. 그 결과는 아래 표 4)에 나타내었다.In order to confirm the degree of skin irritation, 20 female experimenters evaluated the degree of stimulation 24 hours after applying the patch test with the Example 2 prescription and the Comparative Example 2 prescription sample inside the upper arm. The results are shown in Table 4 below.

표 4)Table 4

구 분division 피부자극결과 평균Skin irritation results 자극성 판정Irritancy judgment 비고(자극성판정)Remarks (Irritation judgment) 실시예 2 처방Example 2 Prescription 13.513.5 22 1. 최소 자극(10이하)2. 약한 자극(10-20)3. 보통 자극(20-30)4. 약간 심한 자극(30-40)5. 심한 자극(40 이상)Minimum stimulation (less than 10) 2. Mild irritation (10-20) 3. Moderate stimulation (20-30) 4. Slightly severe irritation (30-40) 5. Severe irritation (over 40) 비교예 2 처방Comparative Example 2 Prescription 33.933.9 44

패치테스트에서는 자극원인 물질로서 AHA의 일종인 글리콜릭 애시드를 사용하였고 파디나파보니카 추출물이 글리콜릭 애시드에 의한 자극을 얼마나 완화시키는지 확인한 결과 비교예 2 처방에서는 평균치로 약간 심한 자극이 나타났으나 실시예 2 처방에서는 약한 자극이 나타나 자극이 현저히 감소함을 볼 수 있다.In the patch test, glycolic acid, a type of AHA, was used as a stimulating agent, and it was confirmed that the padinapabonica extract mitigates the stimulation caused by glycolic acid. In Example 2, the mild stimulus appeared and the stimulus was markedly reduced.

본 발명자는 파디나파보니카 추출물이 글루코스 아미노글루칸 합성을 자극하는 섬유아세포에 작용하여 합성되는 양을 증가시킬 수 있음과 피부 자극이 감소한다는 것을 검증하였고, 나아가 각질세포에서 흡수된 후 섬유아세포로 작용하여 같은 역할을 하는 것을 확인하였으며, 이에 따라 파디나파보니카 추출물을 함유한 본 발명의 화장료 조성물은 피부의 주름을 개선시키고 탄력을 증진시키며 외부 환경의 자극으로부터 피부를 보호할 수 있는 효과를 가져온다.The present inventors have verified that padinapabonica extract can increase the amount synthesized by acting on fibroblasts that stimulate glucose aminoglucan synthesis and decreases skin irritation, and further acts as a fibroblast after absorption from keratinocytes. It has been confirmed that to play the same role, according to the cosmetic composition of the present invention containing the Padina Pabonica extract has the effect of improving the wrinkles of the skin, improve the elasticity and protect the skin from stimulation of the external environment.

Claims (2)

피부 자극을 완화하고 글루코스 아미노글루칸의 합성을 자극하여 피부의 탄력증진과 주름개선을 촉진하는 파디나파보니카 추출물을 함유한 것을 특징으로 하는 화장료 조성물.A cosmetic composition comprising padinapabonica extract for alleviating skin irritation and stimulating the synthesis of glucose aminoglucan to promote skin elasticity and wrinkle improvement. 제1항에 있어서, 파디나파보니카 추출물의 함유량이 화장료 조성물을 기준으로 0.1 내지 20.0 중량%인 것을 특징으로 하는 화장료 조성물.The cosmetic composition according to claim 1, wherein the content of the padinapabonica extract is 0.1 to 20.0 wt% based on the cosmetic composition.
KR10-2000-0060708A 2000-10-16 2000-10-16 Cosmetic material containing Padina Pavonica extract Expired - Lifetime KR100419134B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR10-2000-0060708A KR100419134B1 (en) 2000-10-16 2000-10-16 Cosmetic material containing Padina Pavonica extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2000-0060708A KR100419134B1 (en) 2000-10-16 2000-10-16 Cosmetic material containing Padina Pavonica extract

Publications (2)

Publication Number Publication Date
KR20020030141A true KR20020030141A (en) 2002-04-24
KR100419134B1 KR100419134B1 (en) 2004-02-14

Family

ID=19693660

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2000-0060708A Expired - Lifetime KR100419134B1 (en) 2000-10-16 2000-10-16 Cosmetic material containing Padina Pavonica extract

Country Status (1)

Country Link
KR (1) KR100419134B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2896692A1 (en) * 2006-01-30 2007-08-03 Jean Alexis Grimaud NEW COSMETOLOGICAL AND DERMATOLOGICAL COMPOSITIONS BASED ON ALGAE EXTRACTS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3476870B2 (en) * 1993-09-16 2003-12-10 株式会社海藻資源研究所 Natural antioxidants
US5649567A (en) * 1995-06-12 1997-07-22 Itt Fluid Technology Corporation Sealing arrangement, for use with, and in combination with, a steam and fuel oil control and furge valve, and a valve seat therefor
JP3807782B2 (en) * 1995-06-22 2006-08-09 ライオン株式会社 Hyaluronidase inhibitor
FR2743723B1 (en) * 1996-01-18 1998-04-17 Texinfine Sa USE OF EXTRACT FROM PLANTS OF THE DICTYOTAL FAMILY FOR THE PREPARATION OF PREPARATIONS FOR REFORMING THE GLYCOSYL ELEMENTS OF THE EXTRACELLULAR MATRIX OF LIVING TISSUES
KR100254794B1 (en) * 1997-09-12 2000-05-01 한승희 Cosmetics composition for body and manufacturing process for the composition

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2896692A1 (en) * 2006-01-30 2007-08-03 Jean Alexis Grimaud NEW COSMETOLOGICAL AND DERMATOLOGICAL COMPOSITIONS BASED ON ALGAE EXTRACTS
WO2007085946A3 (en) * 2006-01-30 2008-03-06 Texinfine Sa Novel cosmetic and dermatological compositions based on algae extracts

Also Published As

Publication number Publication date
KR100419134B1 (en) 2004-02-14

Similar Documents

Publication Publication Date Title
US8071106B2 (en) Topical formulation containing latex of fraction thereof, and cosmetic treatment method
US11285093B2 (en) Cosmetic uses of swertiamarin
JPH10509735A (en) Use of vitamin C or a derivative thereof or an analog thereof for promoting skin elastin synthesis
CN104721129A (en) Microemulsion biotechnology skin care product
US20100233111A1 (en) Gastropod biological fluid, method of making and refining and use
US5955083A (en) Use of eriobotrya japonica extract, in particular in cosmetics for stimulating glycosaminoglycan synthesis
CN109998986A (en) One kind two splits yeast freeze-dried powder preparation and preparation method thereof
WO2009002982A2 (en) Gastropod biological fluid, method of making and refining and use
KR102144568B1 (en) Composition for skin conditioning comprising Morus alba L. extract
KR20110052095A (en) Cosmetic composition for moisturizing skin containing mushroom extract
KR102606356B1 (en) Cosmetic composition for regenerating skin and improving skin wrinkle
US20180353413A9 (en) Skin compositions containing hydrocortisone
CN118384056A (en) Chitosan sun-proof skin care composition and preparation method thereof
KR100419134B1 (en) Cosmetic material containing Padina Pavonica extract
KR100429590B1 (en) Anti-wrinkle cosmetics comprising Ecklonia cava extracts
KR102253894B1 (en) Skin regeneration, skin moisturizing and skin whitening composition containing diatomaceous earth
KR20050097578A (en) Cosmetic composition containing the zizyphus jujuba fruit extract and walnut extract for moisturizing effect on the skin
KR100444196B1 (en) Cosmetic composition containing medical plant complex extracts stabilized with nanoliposome
KR20170030836A (en) External composition for antiaging comprising osthole
CN112641685A (en) Moisturizing and circulation promoting essence and preparation method thereof
KR100695996B1 (en) Niosome containing natural situation mushroom extract and cosmetic composition containing same
JPH10182402A (en) Agent for promoting synthesis of hyaluronic acid
WO2005044241A1 (en) Transdermal firming serum
CN117017845A (en) Application of Sparassis crispa concentrated solution, anti-aging whitening composition and cosmetic
KR100364289B1 (en) Skin care composition

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20001016

PA0201 Request for examination
N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20020110

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20021022

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20030116

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20021022

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20030214

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20030116

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20031230

Appeal identifier: 2003101000501

Request date: 20030214

AMND Amendment
PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20030310

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20030214

Patent event code: PB09011R01I

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20030513

Patent event code: PE09021S01D

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

Patent event date: 20031230

Comment text: Decision to Grant Registration

Patent event code: PB07012S01D

Patent event date: 20030326

Comment text: Transfer of Trial File for Re-examination before a Trial

Patent event code: PB07011S01I

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20040204

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20040205

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20070104

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20080201

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20090105

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20100105

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20110104

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20120102

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20130102

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20130102

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20140203

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20140203

Start annual number: 11

End annual number: 11

FPAY Annual fee payment

Payment date: 20150204

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20150204

Start annual number: 12

End annual number: 12

FPAY Annual fee payment

Payment date: 20160111

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20160111

Start annual number: 13

End annual number: 13

FPAY Annual fee payment

Payment date: 20170109

Year of fee payment: 14

PR1001 Payment of annual fee

Payment date: 20170109

Start annual number: 14

End annual number: 14

FPAY Annual fee payment

Payment date: 20180109

Year of fee payment: 15

PR1001 Payment of annual fee

Payment date: 20180109

Start annual number: 15

End annual number: 15

PR1001 Payment of annual fee

Payment date: 20190218

Start annual number: 16

End annual number: 16

FPAY Annual fee payment

Payment date: 20200128

Year of fee payment: 17

PR1001 Payment of annual fee

Payment date: 20200128

Start annual number: 17

End annual number: 17

PC1801 Expiration of term
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载